| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_95040620b9415121b6e0320e93aa440f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-324
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-635 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-78 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-74 |
| filingDate |
2019-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa789d9aae404929da020c396d626ff1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be249345dd4603e70474051c114625db |
| publicationDate |
2019-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2019141791-A1 |
| titleOfInvention |
Biomarker predicting coronary artery disease |
| abstract |
Method of determining the health risk for myocardial infartion inpatients subjected to coronary angiography or suspected having an increased cardio-vascular health risk, wherein the concentration of parathyroid hormone is determined in vitro in serum or plasma sample of said patient wherein that the serum or plasma sample is contacted with beads binding oxidized parathyroid hormone and correlating the determined level of parathyroid hormone to the risk for myocardial infarction. |
| priorityDate |
2018-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |